<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-108803-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Atelier sur les vaccins novateurs visant &#xE0; lutter contre la r&#xE9;sistance aux antimicrobiens chez les animaux producteurs d&#x2019;aliments</narrative>
   <narrative xml:lang="EN">Workshop on innovative vaccines and prophylactic innovations to address antimicrobial resistance in food-producing animals</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Le probl&#xE8;me grandissant de la r&#xE9;sistance aux antimicrobiens (RAM) menace de r&#xE9;duire notre capacit&#xE9; &#xE0; traiter efficacement les infections bact&#xE9;riennes chez les humains et les animaux. Le principal facteur du d&#xE9;veloppement et de la propagation de la RAM est l&#x2019;utilisation r&#xE9;pandue des antimicrobiens en m&#xE9;decine humaine et animale, ainsi que dans la production de b&#xE9;tail (Organisation mondiale de la Sant&#xE9;, 2000). De plus, la contamination de produits d&#x2019;origine animale avec des bact&#xE9;ries r&#xE9;sistantes aux antimicrobiens a &#xE9;t&#xE9; signal&#xE9;e comme &#xE9;tant un facteur de risque pour les infections humaines par des organismes r&#xE9;sistants. 

Le CRDI et le minist&#xE8;re de la Sant&#xE9; du Royaume-Uni travaillent ensemble en vue d&#x2019;&#xE9;tablir un nouveau programme de recherche qui mettra l&#x2019;accent sur les innovations visant &#xE0; r&#xE9;duire l&#x2019;utilisation d&#x2019;antimicrobiens dans les pays &#xE0; faible revenu et &#xE0; revenu interm&#xE9;diaire, ce qui r&#xE9;duira le risque de RAM.  Ce nouveau programme est financ&#xE9; gr&#xE2;ce &#xE0; l&#x2019;actuel Fonds d&#x2019;innovation en vaccins pour le b&#xE9;tail, un partenariat entre la Fondation Bill et Melinda Gates, Affaires mondiales Canada et le CRDI. Il s&#x2019;agit d&#x2019;un investissement conjoint de 57 millions CAD sur cinq ans qui permet de financer le d&#xE9;veloppement, la production et la commercialisation de vaccins innovants contre les maladies du b&#xE9;tail prioritaires en Afrique subsaharienne, en Asie du Sud et en Asie du Sud-Est.

 Afin d&#x2019;obtenir autant de renseignements et d&#x2019;expertise que possible, le CRDI et le minist&#xE8;re de la Sant&#xE9; du Royaume-Uni &#xE9;tabliront un partenariat pour organiser un atelier multisectoriel, interdisciplinaire et pr&#xE9;alable &#xE0; la mise en &#x153;uvre, lequel portera sur la collecte de donn&#xE9;es probantes afin de cerner les lacunes dans la recherche sur la RAM et d&#x2019;&#xE9;clairer les futurs programmes sur la RAM chez les animaux producteurs d&#x2019;aliments, plus particuli&#xE8;rement la volaille, les porcs, les poissons et les animaux d&#x2019;aquaculture. L&#x2019;atelier r&#xE9;unira des experts internationaux en mati&#xE8;re de RAM; des experts du secteur manufacturier priv&#xE9; et public provenant des r&#xE9;gions d&#xE9;velopp&#xE9;es et en d&#xE9;veloppement; des r&#xE9;seaux r&#xE9;gionaux et nationaux en mati&#xE8;re de RAM; et d&#x2019;autres organisations pertinentes. 

De plus, le CRDI et le minist&#xE8;re de la Sant&#xE9; du Royaume-Uni &#xE9;tabliront un partenariat avec l&#x2019;organisme Wilton Park House (Royaume-Uni), qui fait participer d&#x2019;importantes communaut&#xE9;s d&#x2019;experts aux dialogues visant &#xE0; traiter et &#xE0; r&#xE9;gler les questions d&#x2019;une importance cruciale pour la s&#xE9;curit&#xE9;, la prosp&#xE9;rit&#xE9; et la justice dans le monde.</narrative>
   <narrative xml:lang="EN">The growing problem of antimicrobial resistance (AMR) threatens to reduce our ability to effectively treat bacterial infections in humans and animals. The primary contributor to the development and spread of AMR is the wide use of antimicrobials in human and animal medicine, and in livestock production (World Health Organization, 2000). The contamination of animal products with antimicrobial-resistant bacteria has also been identified as a risk factor for human infections with resistant organisms. There are opportunities to address the non-therapeutic and inappropriate use of antibiotics in food-producing animals through the development of new tools, including vaccines.

The UK Department of Health and IDRC are working together to establish a new research program focusing on innovations aimed at reducing antimicrobial use in low and middle-income countries and thus reducing the risk of AMR through vaccines and other prophylactic tools. This new program is building on the IDRC&#x2019;s existing Livestock Vaccine Innovation Fund, a partnership of the Bill and Melinda Gates Foundation, Global Affairs Canada, and IDRC. It represents a joint investment of CA$57 million over five years to support the development, production, and commercialization of innovative vaccines against priority livestock diseases in sub-Saharan Africa, South Asia, and Southeast Asia.

 In order to collect as much information and expertise as possible, the Department of Health UK and IDRC will partner to host a multi-sectoral, interdisciplinary pre-implementation workshop focused on gathering evidence to identify the gaps in AMR research and inform future programming in AMR in food-producing animals, specifically poultry, swine, fish and aquaculture animals. The workshop will bring together international experts in AMR and livestock and aquaculture animal health, production and vaccines; experts from the public and private manufacturing sector from developing and developed regions; national and regional AMR networks; and other relevant organizations. 

IDRC and the UK Department of Health will partner with Wilton Park House (UK), which engages key communities of experts in dialogue to address and resolve issues of critical importance to global security, prosperity, and justice. Wilton Park uses the trust and the global convening power that it has acquired through decades of engagement in various dimensions of foreign affairs.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="15">
   <narrative xml:lang="EN">Wilton Park Executive Agency</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">Wilton Park Executive Agency</narrative>
  </participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2018-03-01" type="2"></activity-date>
  <activity-date iso-date="2018-06-01" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="2" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Increasing food security</narrative>
   <narrative xml:lang="FR">S&#xE9;curit&#xE9; alimentaire</narrative>
  </sector>
  <sector code="31182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-03-30"></transaction-date>
   <value currency="CAD" value-date="2018-03-30">150000</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wilton Park Executive Agency</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-03-31"></transaction-date>
   <value currency="CAD" value-date="2018-03-31">139500</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wilton Park Executive Agency</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-09-28"></transaction-date>
   <value currency="CAD" value-date="2018-09-28">-30226</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wilton Park Executive Agency</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
